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Purpose: We evaluated the usefulness of intracranial stent implantation for treating patients with ather-
osclerotic stenosis and with recurrent, ischemic, neurological symptoms despite having undergone
medical therapy.
Materials and Methods: Between March 2004 and April 2010, we attempted intracranial, stent-assisted
angioplasty in 77 patients with 85 lesions (anterior circulation 73 cases, posterior circulation 12
cases) and who had ischemic neurological symptoms with more than 50% major cerebral artery
stenosis. We analyzed the results regarding the technical success rate, complication rate, and re-
stenosis rate during the mean 29.4 month follow-up period.
Results: Intracranial stent implantation was successfully performed in 74 cases (87.1%). In nine cases
among the 11, failed cases, stent implantation failure was due to the tortuosity of the target vessel.
One patient experienced middle cerebral artery rupture during the procedure, and we embolized
the vessel using a microcoil. Five patients developed cerebral infarction in three weeks after the
procedure, three of whom improved using conservative management, although the other, two
patients expired. The mean number of residual stenoses decreased from 72.3% to 14.7%. Three
patients demonstrated significant in-stent restenosis, i.e. more than 50%, during the follow-up
period.
Conclusion: As stent-assisted angioplasty in intracranial, atherosclerotic stenosis is effective and relative-
ly safe, it can be considered as an alternative treatment for patients with recurrent, ischemic, neu-
rologic symptoms despite having undergone medical therapy.
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http://dx.doi.org/10.5469/neuroint.2012.7.1.27Stroke is the second most important cause of death in
Korea followed by cancer and it is the leading cause of
physical disability in Koreans [1]. In Asians, the
incidence and mortality rate due to stroke is higher than
that in the Western population, although the rate of
coronary heart disease is lower in Asians. Racial differ-
ences have been suggested in the distribution of
cerebral atherosclerosis [2].
Little is known about the natural history of stenosis
caused by intracranial atherosclerosis.  However, as
many as 6-29% of all ischemic strokes are related to
stenotic lesions located in large, intracranial vessels,
and an increased risk for stroke, heart disease, and
death has been consistently observed [3]. In a Warfarin
Aspirin Symptomatic Intracranial Disease (WASID)
trial, 14% and 23% of the patients who had a transient
ischemic attack (TIA) or stroke attributed to a high-
grade, intracranial stenosis had another ipsilateral
ischemic stroke during the following year of that study
even though they were on medical therapy [4].
Recently, percutaneous transluminal angioplasty and
stenting have been proposed as an alternative treatment
for patients with intracranial atherosclerotic stenosis
symptoms despite their medical therapy [5, 6].
We report here our results for angioplasty/stenting the
intracranial arteries of 85 consecutive patients. We have
included the early and late clinical outcomes, and we
compared our results to those which have already been
reported in the literature.
MATERIALS AND METHODS
Between March 2004 and April 2010, 85 intracranial
arteries in 77 patients were treated by means of stent-
assisted angioplasty at our institutions. The inclusion
criteria for stent-assisted angioplasty were recurrent
symptoms caused by intracranial artery stenosis while
the patient was being treated with the optimal dose of
an antiplatelet or anticoagulation medication and
angiographically proven, significant atherosclerotic
stenoses (more than 50%) that were responsible for the
patients’ symptoms. The patient age ranged from 37 to
77 years (mean, 60.8 years). There were 43 males and
42 females. The institutional review board approved
this retrospective study and waived informed consent.
All the patients underwent preoperative computed
tomography (CT) or magnetic resonance imaging
(MRI) or both as well as cerebral digital subtraction
angiography. Pre-procedural quantitative angiographic
measurements were obtained in both the target vessel
and the lesion. The degree of stenosis was calculated
according  to  the  NASCET  (North  American
Symptomatic Carotid Endarterectomy Trial) criteria for
grading carotid stenosis. All patients were treated
electively and were premedicated with aspirin 100 mg
and clopidogrel 75 mg for a minimum of three days
prior the intervention. All procedures were done under
local anesthesia, and during the procedures each patient
received 5,000-8,000 IU of intravenous heparin in
order to attain an activated clotting time (ACT) of more
than 250 seconds. Percutaneous access was obtained
via a femoral artery.  Access to the stenotic artery was
achieved using a 6F guiding catheter (Envoy; Cordis
Endovascular Corporation, Miami, FL, U.S.A.). The
stenotic lesion was crossed using a 0.010-0.014 inch
microguidewire, and the balloon catheter was placed
over the microguidewire and then directed across the
lesion. We used balloon catheters with diameters
ranging from 2 to 3 mm and with lengths of 10 or 20
mm, according to the target vessel size, and we were
careful not to allow any over-dilatation. Balloon
inflation was performed slowly and was maintained for
10 to 20 seconds using a disposable inflation device
that allowed for exact pressure control. In all, we
implanted eight kinds of stents, i.e. 46 Endeavor
(Medtronic Vascular, n=46), Vision (Abbott, n=14),
Flexmaster (Abbott, n=10), Arthos pico (AMG
International, n=6), Neuroform (Boston Scientific,
n=3), Guidant (Abbott, n=3), Tsunami (Terumo n=2),
and Driver (Medtronic Vascular, n=1).
Antiplatelet therapy with clopidogrel and aspirin was
continued for 4-12 weeks following the treatment, and
then aspirin was continued during the remainder of
each patient’s life. Additional boluses of heparin were
given to the patients during the procedure in order to
maintain an ACT between 200 and 250 seconds and
28 Neurointervention 7, February 2012
Kuk Seon Kim, et al.
Table 1. Summary of 85 Cases of Intracranial Stenting
Characteristic Value
Patient (n = 77)
Mean age 60.8 years
Male : Female 43 : 42
Location (n = 85)
ICA 40
MCA 33
Basilar artery 8
Vertebral artery 4
Abbreviations: ICA, intracranial carotid artery; MCA, middle
cerebral artery (10%)which was not reversed at the end of the procedure.
We evaluated the procedure success rate, the peripro-
cedural complications during the 30-day periprocedural
period, and any symptom recurrence or restenosis
which occurred during the mean 29.4 month (from 3 to
72 months) follow-up period. We defined procedural
success as a final luminal narrowing of less than 30%
of the normal luminal diameter. Angiographic resteno-
sis seen on conventional cerebral angiography was
defined as stenosis of more than 50% of the luminal
diameter.
The stenosis rates before and after stent-assisted
angioplasty and those seen on follow-up were
compared using the paired Student’s t-test. A probabil-
ity of P less than .05 was considered statistically signif-
icant. SPSS 17.0 (SPSS-PC Inc., Chicago, IL, U.S.A.)
statistical software was used.
RESULTS
The patient characteristics and lesion locations are
summarized in Table 1. The lesion locations were the
intracranial internal carotid artery (ICA) (n=40) (Fig.
1), middle cerebral artery (MCA) (n=33), vertebral
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Fig. 1. 62-year-old male who presented left-side hemiparesis and dysarthria.
A. Diffusion-weighted MRI revealed acute infarction in the right parietal lobe.
B. Pre-procedural angiography showed luminal narrowing of the distal right ICA.
C. Post-procedural angiography showed good patency of the flow.
D. Follow-up angiography eight months after the procedure showed no restenosis.
A Bartery (n=8), and basilar artery (n=4). Available
angiograms showed significant improvement of the
stenosis, with the mean preprocedural stenosis of the
treated lesion being 72.3% (range, 63-90%) and the
mean postprocedural residual stenosis 14.7% (range,
0-25%).
The overall success in reaching the target lesion with
stents was 87.1% (74 of 85 targets), while nine
procedures were aborted because of our inability to
manipulate the device in the tortuous anatomy of an
ICA (n=8) or an aortic arch (n=1). One procedure
failed technically because of kinking of the device.
Another procedure failed because insufficient sedation
resulted in poor patient cooperation.
In one patient, the MCA was ruptured during the
balloon dilatation and the ruptured segment was
occluded with microcoils. Follow-up CT scanning
showed progressively decreasing subarachnoid
hemorrhage and no neurological symptoms.
Table 2 summarizes the clinical and technical results
and provides the follow-up data. Nine patients were
lost to follow-up, and the data of patients who did not
undergo stent implantation were excluded. Therefore,
clinical follow-up was available in 65 patients, and the
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Fig. 2. 69-year-old female who presented right hemiparesis and dysarthria.
A. Angiography showed severe stenosis in the left MCA in the distal M1 portion.
B. After stent-assisted angioplasty, the left MCA was completely recanalized.
C, D. The patient presented with recurrent ischemic neurologic symptoms on the contralateral side six months after the procedure. As
her symptoms were related to severe stenosis in the right MCA M1 segment, stent-assisted angioplasty was performed.
AB
Continuedfollow-up period ranged from three to 72 months
(mean follow-up, 29.4 months). Clinical success was
defined as a patient having no recurrent symptoms or
angiographic restenosis and was observed in 84.6% of
our patients (55 of 65 cases).
During the follow-up period, two patients developed
TIA symptoms and all of their MR examinations
revealed newly developed ischemic or infarcted lesions
associated with the artery we had already treated. The
symptoms and lesions improved in both of these
patients with the use of heparin and conservative
management. Two other patients developed subacute
occlusion of the treated arteries (ICA) three weeks after
the procedure. Both of these patients expired five
weeks after the procedure due to multifocal intracranial
hemorrhage. One patient chose to stop taking the
anticoagulant  drugs,  and  ischemic  neurologic
symptoms began to develop two weeks after the
procedure, MR imaging revealed a newly developed
infarction, and an angiogram showed subacute
occlusion of treated artery (MCA). The lesion
developed hemorrhagic transformation one week later,
and a follow-up CT scan showed progressively improv-
ing lesions without neurologic sequalae. One patient
died six weeks following the procedure because a slip
down resulted in a traumatic intracerebral hematoma, 6
weeks after the procedure.
Conventional angiographic follow-up was available
in 31 of the 74 study patients. One patient who
presented right hemiparesis and dysarthria had severe
stenosis in the left MCA distal M1 portion. Six months
after stent-assisted angioplasty, the ischemic neurologic
symptom recurred and angiography showed MCA
stenosis of the opposite side. Another stent was then
implanted in the right MCA. After 19 months, follow-
up angiography showed no restenosis in either MCA
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Fig. 2. E, F. Follow-up angiography performed both 13 and 19 months after the procedure, shows good flow patency with stent implanta-
tion in the right and left MCA, respectively.
Table 2. Summary of the Procedural and Follow-up Results
Characteristic Value
Technical results
Technical success rate 87.1% (74/85)
Technical failure rate 12.9% (11/85)
Stenosis
Pre-procedural stenosis 72.3%
Post-procedural stenosis 14.7%
Complications
MCA rupture    1
*Ischemic stroke 5
�Death 3
Follow-up results
No significant change 61
Re-stenosis 4
Follow-up loss 9
TIA: Transient ischemic attack
* Including 2 transient ischemic attack
�Two reperfusion injury after subacute infarction and one
traumatic intracerebral hematomastent (Fig. 2). Three patients showed restenosis of the
stent-treated artery during the follow-up period. One
patient in whom another stent was implanted in the
ICA, developed ischemic symptoms three month later.
She then underwent superficial temporal artery-middle
cerebral artery bypass surgery. In one patient who
underwent balloon dilatation, no further restenosis was
observed on the follow-up angiogram. Another patient
showed restenosis on the follow-up angiogram, but was
without symptoms.
DISCUSSION
The indication for stenting of intracranial vessels
depends on both the risks of the untreated or the
medically treated disease and the safety and effective-
ness of the interventional procedure [7]. The natural
history of intracranial stenoses has not been studied as
well as that of extracranial stenoses, although intracra-
nial stenoses consistently have a high incidence of
stroke. In one study, patients with intracranial ICA
stenoses and who were followed for an average of 3.9
years had a TIA or stroke rate of 27.3% [3].
In the External Carotid/Internal Carotid Artery
Bypass Trial [8], the medical patient group, i.e. those
treated with aggressive stroke risk factor management
and 1300 mg of aspirin daily, had an annual mortality
and stroke rate of 8% to 10%. In the WASID trial [4],
the one-year rate of ischemic stroke in the territory of
the stenotic artery was approximately 12% in those
patients with symptomatic intracranial stenosis of more
than 50% and who were treated with either aspirin or
warfarin. And in the GESICA study [9], the two-year
recurrence rate of ischemic events in the territory of the
stenotic artery, was 38.2% despite medical treatment.
Because of continually advancing device technology,
intracranial stenting is now feasible. However, the
clinical outcome varies from moderate- to high-risk
rates for morbidity and mortality. To date, the only
prospective, multicenter study that has been conducted
is the SSYLVIA study [10] which demonstrated stroke
rates of 6.6% and 13.1% at 30 days and one year,
respectively.
In our clinical experience, stent implantation for
intracranial atherosclerotic stenosis had a relatively
high success rate (87.1%) and few procedure-related
complications (1.2%), and most of our patients who
had a successful procedure experienced good clinical
outcomes and were free of ischemic symptoms. Our
restenosis rates (4.0%) are similar to those of previous
reports [11].
In this study, the angiographic follow-up data is
limited because clinically symptom-free patients
without any ischemic lesion seen on follow-up MRI
examination, did not have to undergo follow-up
angiography. As we considered patients with a good
clinical outcome as those without significant restenosis,
this may have affected our low rate of restenosis.
Five patients (6.5%) developed subacute occluded
infarction or intracranial hemorrhage as following
stent-assisted angioplasty of intracranial vessels, there
is a high risk for intracranial hemorrhage, particularly
within the first hours after the treatment, and due to
hyperperfusion of the previously hypoperfused brain
parenchyma with lost autoregulation or small vessel
injury in recently infarcted tissue. Therefore, patients’
blood pressure must be controlled, and large to prevent
subacute infarction [11].
Angulation and tortuosity of an affected vessel are
the most important factors in failed stent implantation.
As they may also be associated with stent rigidity and
overcome technical problem, we expect an increasing
success rate as we gain more clinical experience and
with improvement of the device [13].
Stent-assisted angioplasty for intracranial stenosis is
becoming increasingly available for applying in
medical refractory stenosis and is being used in patients
before other types of surgical therapy. Before the
interventional procedure, both a perfusion study and a
reserve capacity test must be obtained. Evaluation of
the morphology and localization of the stenosis by
preprocedural angiography, are also needed. In
addition, side branches and perforators closing the
stenotic lesion are important informations those should
be evaluated before stent implant [14].
As stent-assisted angioplasty used to treat intracranial
atherosclerotic stenosis, is both effective and relatively
safe, it should be considered as an alternative treatment
for patients with recurrent ischemic neurologic
symptoms despite having undergone medical therapy.
However, large patient cohorts and long-term follow-
up data will be needed in order to provide positive
evidence of its considerable benefit. We expect that
increased clinical experience and improvement of the
device will allow high clinical success rate and a low
number of procedural complications.
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